Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients

por Ou, Sai-Hong Ignatius, Horn, Leora, Cruz, Marcelo, Vafai, Davood, Lovly, Christine M., Spradlin, Allison, Williamson, Michael J., Dagogo-Jack, Ibiayi, Johnson, Adrienne, Miller, Vincent A., Gadgeel, Shirish, Ali, Siraj M., Schrock, Alexa B.
Publicado 2017